Chris Rader Buys Shares of HBCP Amid Insider Activity

Chris Rader recently purchased 100 shares of HBCP on June 12, 2026. The transaction did not disclose a price or total value, but it was part of a series of insider trades on the same day, reflecting continued interest in the company's stock.

Insider Buying and Selling at HBCP

Several insiders were active in trading HBCP shares on June 12, 2026. Alongside Chris Rader, Trappey Ann Forte, Daniel Guidry, John Scott Ballard, and Paul Blanchet each bought 100 shares. Meanwhile, Mark Herpin, the Senior Executive Vice President and Chief Operations Officer, sold 110 shares at $68.08 per share. None of these transactions were planned trades under Rule 10b5-1.

Other Institutional Activity in HBCP

Institutional investors have also been adjusting their stakes in HBCP. Dimensional Fund Advisors LP increased its holdings by 7,792 shares, bringing its total to 429,581 shares worth about $26.02 million. BlackRock, Inc. reduced its position by 6,737 shares, ending with 411,940 shares valued at approximately $24.96 million. Vanguard Capital Management LLC saw a significant increase, adding 295,778 shares to reach the same number in total, valued at $17.92 million. American Century Companies Inc grew its stake by 25,614 shares, now holding 186,588 shares worth $11.30 million. Conversely, Crawford Fund Management, LLC decreased its position by 8,989 shares, leaving it with 161,459 shares valued at $9.78 million.

HBCP Stock Snapshot

Shares of HBCP traded near $68.08. The stock is actively followed by investors, with various institutional activities indicating differing levels of confidence in the company's future performance.

Analysts Set New Price Targets

On April 22, 2026, Piper Sandler downgraded HBCP to a hold rating, setting a price target of $69. This reflects a cautious outlook compared to previous assessments. Raymond James maintained a buy rating with a target of $62 as of July 23, 2025. Overall, analysts have varied opinions, with some maintaining positive outlooks despite recent downgrades.

Bottom Line

The recent insider buying by Chris Rader and others highlights continued interest in HBCP. Institutional investors have shown mixed actions, with some increasing and others decreasing their holdings. Analyst opinions also vary, suggesting differing views on the company's future performance. As always, it's important to remember that insider and institutional activities are backward-looking and may not reflect current positions or future moves.